Abstract | OBJECTIVE: DESIGN: Retrospective analysis of follow up data on 34 children with JIA who were treated with ASCT in nine different European transplant centres. Rheumatological evaluation employed a modified set of core criteria. Immunological reconstitution and infectious complications were monitored at three month intervals after transplantation. RESULTS: Clinical follow up ranged from 12 to 60 months. Eighteen of the 34 patients (53%) with a follow up of 12 to 60 months achieved complete drug-free remission. Seven of these patients had previously failed treatment with anti-TNF. Six of the 34 patients (18%) showed a partial response (ranging from 30% to 70% improvement) and seven (21%) were resistant to ASCT. Infectious complications were common. There were three cases of transplant related mortality (9%) and two of disease related mortality (6%). CONCLUSIONS: ASCT in severely ill patients with JIA induces a drug-free remission of the disease and a profound increase in general wellbeing in a substantial proportion of patients, but the procedure carries a significant mortality risk. The following adjustments are proposed for future protocols: (1) elimination of total body irradiation from the conditioning regimen; (2) prophylactic administration of antiviral drugs and intravenous immunoglobulins until there is a normal CD4+ T cell count.
|
Authors | I M De Kleer, D M C Brinkman, A Ferster, M Abinun, P Quartier, J Van Der Net, R Ten Cate, L R Wedderburn, G Horneff, J Oppermann, F Zintl, H E Foster, A M Prieur, A Fasth, M A J Van Rossum, W Kuis, N M Wulffraat |
Journal | Annals of the rheumatic diseases
(Ann Rheum Dis)
Vol. 63
Issue 10
Pg. 1318-26
(Oct 2004)
ISSN: 0003-4967 [Print] England |
PMID | 15361393
(Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Arthritis, Juvenile
(immunology, therapy)
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Graft Survival
- Health Status Indicators
- Humans
- Infant
- Male
- Opportunistic Infections
(etiology)
- Patient Selection
- Retrospective Studies
- Severity of Illness Index
- Stem Cell Transplantation
(adverse effects, methods)
- Survival Analysis
- T-Lymphocyte Subsets
(immunology)
- Transplantation Conditioning
(methods)
- Transplantation, Autologous
- Treatment Outcome
|